Tag: medium vessel occlusion
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...
Is thrombectomy set to become the standard of care for medium...
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes...
DISTAL trial will elucidate non-dominant M2, M3 and PCA occlusions but...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December...
DISTAL: A landmark trial looking to elucidate endovascular treatment outcomes in...
In December 2021, University Hospital Basel (Basel, Switzerland) enrolled the first patient worldwide in the DISTAL study—a multicentre randomised controlled trial (RCT) evaluating the...
